1.CT-guided percutaneous ethanol ablation of parathyroid adenoma
Changjing ZUO ; Shen QU ; Jianmin TIAN
Journal of Interventional Radiology 1994;0(02):-
Objective To validate the theraputic efficacy of percutaneous ethanol injection(PEI) for hyperparathyroidism caused by parathyroid adenoma.Methods One case of parathyroid adenoma underwent PEI whose diagnosis was comfirmed by biopsy. The 22 gauge needle was punctured into the adenoma under CT guidance and ethanol was injected into the lesion at multiple points. Results The CT images obtained 6 months after 2 times of CT guided PEI revealed that the volume of the adenoma decreased markedly together obviously with decrease of enhancement after the injection of contrast media. The level of serum parathyroid hormone, calcium and phosphorous returned normal 2 days to 12 months after the management. The clinical manifestations improved markedly.Conclusions CT guided PEI is a minimally invasive and highly effective theraputic modality for hyperparathyroidism. It can serve as an important supplement to surgery.
2.Changes in heart rate variability in patients after coronary artery bypass graft
Zhengping WANG ; Hao SHEN ; Suning ZUO
Chinese Journal of Anesthesiology 1995;0(12):-
Objective To investigate the significance of the changes in heart rate variability (HRV) in patients undergoing coronary artery bypass graft procedure Methods Thirty six patients scheduled for elective coronary artery bypass were studied HRV was monitored by HXD I monitoring system one day prior to surgery (as baseline values), before anesthesia, at the end of surgery and on the 3rd day and 6th day after surgery Results The baseline logical values for total power(TP), low frequency (LF), high frequency (HF), LF/HF ratio were 3 07?0 35, 2 38?0 47, 2 37?0 54 and 1 34?0 93 respectively There were no significant changes in all these parameters before anesthesia as compared to baseline values LF,HF and TP decreased significantly on the 3rd day after surgery as compared with baseline values, and were kept at the level on the 6th postoperative day Conclusions The decrease in HRV power can last over 6 days after coronary bypass graft surgery, signifying reduced autonomous regulation of heart in the early postoperative days
3.Observation of influence of FTY720 on peripheral blood lymphocytes and T cell subsets of mice in vivo
Lei ZHANG ; Liqun ZUO ; Shiqian SHEN
Chinese Journal of Urology 2000;0(01):-
Objective To investigate the influence of FTY720 on the lymphocytes and their recovery after withdrawal of FTY720,and on the changes in T cell subsets of inbred mice so as to direct the administration of FTY720. Methods Male inbred C57/bl mice were given FTY720 at the dose of 3 mg/kg per day by oral gavage once a day for 14 days. The PBLs were counted and T cell subsets were analyzed by flow cytometry at the selected time points. Results When FTY720 was administrated, the PBLs showed a sharp decrease and reached the minimum 4 hours later.Then the PBLs remained stable during the whole pe- riod of administration.The PBLs didn’t restore immediately when the reagent was withdrawn,but increased slowly 2 weeks later and completely recovered 6 weeks later.The changes of T cells were similar to PBLs.CD - 8 subsets showed relatively higher sensitivity to FTY720. Conclusions FTY720 is a safe reagent which has rapid and specific effects on PBLs,and the changes in PBLs are reversible.The effect of FTY720 on T cell subsets is similar to that on PBLs.CD - 8 T cells are relatively more sensitive to FTY720.
4.Alternative Management for Old Lung Cancer Patients (review)
Tao SUN ; Minghuan ZUO ; Yang SHEN
Chinese Journal of Rehabilitation Theory and Practice 2012;18(5):436-439
The incidence of the lung cancer increased as the aging of population. Lung cancer in the aged characterized in feature and treatment. This paper discussed the characteristics, early features, the problems of routine treatment, the alternative managements such as green therapy, assessment and improvement of quality of life, etc., in old lung cancer.
6.Nursing care of patients with neuromyelitis optica spectrum diseases treated with immunoadsorption therapy
Lili LI ; Hengfang RUAN ; Liping SHEN ; Jun ZUO ; Wei QIU
Chinese Journal of Practical Nursing 2021;37(4):286-290
Objective:To explore the application and nursing of protein A immunosorbent in patients with neuromyelitis optica spectrum diseases.Methods:Ten patients with neuromyelitis optica spectrum diseases were treated with protein A immunoadsorption therapy. Psychological nursing was emphasized. Comprehensive evaluation was conducted before adsorption to determine the prescription of adsorption therapy. During adsorption therapy, hypotension, membrane rupture and hemolysis of plasma separator, shivering and other adverse reactions were accurately prevented and treated. After treatment, attention should be paid to the prevention of nosocomial infection, regeneration and preservation of adsorption column.Results:After immunoadsorption therapy, the serum IgG level, antibody and EDSS score of 10 patients decreased to varying degrees. The serum IgG decreased from (6.04±2.77)g/L to (2.23±1.74)g/L. No serious complications occurred, no failure of immunosorbent operation, and the patients′ condition was better than before.Conclusions:Protein A immunosorbent therapy for neuromyelitis optica spectrum diseases is safe and effective. Standardized evaluation, operation and nursing are the key to achieve good results.
7.The relationship between bone morphogenetic proteins-2 gene mutation and coal-burning skeletal fluorosis of children
Zhu SHEN ; Zhen ZUO ; Maojuan YU ; Lingya LU
Chinese Journal of Endemiology 2016;35(2):99-104
Objective To investigated the association between bone morphogenetic proteins-2 (BMP-2)gene mutation and coal-burning skeletal fluorosis of children in Zhijin Guizhou.Methods In 2010,121 cases of children with skeletal fluorosis were diagnosed based on the standard X-ray Diagnosis of Skeletal Fluorosis (WS192-1999) in coal-burning skeletal fluorosis areas in Zhijin Guizhou,and 50 cases of them were selected as skeletal fluorosis group.Thirty healthy children free of skeletal fluorosis,rickets and other bone related diseases excluded by X-ray were selected as a control group in the same area.Using polymcrase chain reaction combined with DNA sequencing technology,all three exons of BMP-2 gene were conducted sequence screening in skeletal fluorosis and the control groups to detect gene mutations.Results ①The T insertion mutation on exon 1 between 401-402 bp:the T insertion mutantion genotype frequencies of skeletal fluorosis group and the control group were 27.7% (13/47)and 7.1% (2/28),and the difference was statistically significant (x2 =4.600,P < 0.05),adjusted OR value of 4.62(1.94-10.90).②)The 894 bp T→G mutation on exon 2:the TG genotype frequencies of skeletal fluorosis group and the control group were 14.0% (7/50) and 16.7%(5/30),and the difference were not statistically significant (x2=0.103,P> 0.05).③The 1 046 bp A→G mutation on exon 2:the AA,AG,GG genotype frequencies of skeletal fluorosis group and the control group was 30.0% (15/50),24.0% (12/50),46.0% (23/50) and 50.0% (15/30),20.0%(6/30),30.0% (9/30),and the differences were not statistically significant (x2 =3.099,P > 0.05).Conclusion Exon 1at 401-402 bp,T insertion mutation and skeletal fluorosis are closely related.The relationship between A→Gmutation in exon 2 at 1 046 bp and skeletal fluorosis is not significant.
8.Research progress of TRAIL network against tumor under the guidance of systems biology
Hui ZUO ; Yuehai SHEN ; Xiaoxi GUO ; Guanlin WANG ; Kwenjen CHANG
Basic & Clinical Medicine 2015;(1):122-125
Tumor is a system-biology illness.Treatment of this intractable disease by any single medicine has not been realistic.In this review, we analyze the anti-tumor network of Tumor Necrosis Factor-related Apoptosis-indu-cing Ligand ( TRAIL ) by a system-biology technology and try to providecin individualized treatment strategy for TRAIL based therapy .
9.Diagnosis and treatment of primary hyperparathyroidism:a report of 8 cases
Tao TAO ; Dajin ZOU ; Shen QU ; Hui LI ; Changjing ZUO ;
Academic Journal of Second Military Medical University 1981;0(03):-
Objective: To study the diagnosis and treatment of primary hyperparathyroidism.Methods: The clinical data of 8 primary hyperparathyroidism patients(1992 2002) in our hospital were summarized and the references were reviewed.Results: It was found that primary hyperparathyroidism was liable to be misdiagnosed.Information on blood calcium,parathyroid hormone(PTH) and imaging may be helpful for diagnosis. Surgical resection(4 cases), anhydrous alcohol injection (2 cases), electron radiation (1 case) and internal medicine (1 case) were applied. Conclusion:Information on blood calcium,PTH and early imaging is helpful for diagnosis.Operation is the first choice of treatment, and for patients who can not tolerate surgery, anhydrous alcohol injection is an effective and safe treatment.
10.Studies on chemical constituents of Callicarpa pedunculata
Yiming HU ; Yuemao SHEN ; Qiongxian GU ; Guoying ZUO ; Xiaojiang HAO
Chinese Traditional and Herbal Drugs 1994;0(12):-
Object To study the chemical constituents of whole plant of Callicarpa pedunculata R Brown Methods Various chromatographic techniques were employed for isolation and purification of its constituents; and their structures were identified by spectral analysis (IR, MS, 1HNMR, 13 CNMR) and chemical evidences Results Ten compounds were obtained from the chloroform extract of the whole plant Among them four were diterpenoids which were identified as: 14 ?-hydroxy-7, 15-isopimaradien-18-oic acid (Ⅰ), 16 ?, 17-dihydroxy-3-oxo-phyllocladanetriol (Ⅱ), 8, 11, 13, 15-abietetraen-18-oic acid (Ⅲ), and 6 ?-hydroxy nidorellol (Ⅳ); 2 flavonoids: 5-hydroxy-3, 4′, 7-trimethoxy-flavone (Ⅴ), and 3, 5-dimethyl kaempherol (Ⅵ); and the others were ursolic acid (Ⅶ), myoinositol (Ⅷ), ?-sitosterol (Ⅸ), and ?-amyrin (Ⅹ) Conclusion Compounds Ⅰ, Ⅱ, Ⅲ, Ⅳ were found in this plant for the first time and it was of interest to note that they were of different diterpenoid skeletons The content of ursolic acid attained to a high level up to 1%, which may be exploited as a natural resource for medical purposes